HRTX vs. SGMO
Compare and contrast key facts about Heron Therapeutics, Inc. (HRTX) and Sangamo Therapeutics, Inc. (SGMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HRTX or SGMO.
Key characteristics
| HRTX | SGMO | |
|---|---|---|
| YTD Return | -30.00% | 277.32% |
| 1Y Return | 29.80% | 484.55% |
| 3Y Return (Ann) | -52.79% | -40.72% |
| 5Y Return (Ann) | -44.04% | -26.31% |
| 10Y Return (Ann) | -17.41% | -15.50% |
| Sharpe Ratio | 0.41 | 3.01 |
| Sortino Ratio | 1.23 | 3.55 |
| Omega Ratio | 1.17 | 1.40 |
| Calmar Ratio | 0.38 | 4.64 |
| Martin Ratio | 1.30 | 10.74 |
| Ulcer Index | 29.58% | 42.96% |
| Daily Std Dev | 93.91% | 153.36% |
| Max Drawdown | -99.96% | -99.40% |
| Current Drawdown | -99.91% | -95.87% |
Fundamentals
| HRTX | SGMO | |
|---|---|---|
| Market Cap | $279.07M | $564.28M |
| EPS | -$0.25 | -$1.38 |
| PEG Ratio | -0.18 | 0.00 |
| Total Revenue (TTM) | $104.93M | $2.88M |
| Gross Profit (TTM) | $76.08M | -$5.20M |
| EBITDA (TTM) | -$19.42M | -$133.70M |
Correlation
The correlation between HRTX and SGMO is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HRTX vs. SGMO - Performance Comparison
In the year-to-date period, HRTX achieves a -30.00% return, which is significantly lower than SGMO's 277.32% return. Over the past 10 years, HRTX has underperformed SGMO with an annualized return of -17.41%, while SGMO has yielded a comparatively higher -15.50% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HRTX vs. SGMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Heron Therapeutics, Inc. (HRTX) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HRTX vs. SGMO - Dividend Comparison
Neither HRTX nor SGMO has paid dividends to shareholders.
Drawdowns
HRTX vs. SGMO - Drawdown Comparison
The maximum HRTX drawdown since its inception was -99.96%, roughly equal to the maximum SGMO drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for HRTX and SGMO. For additional features, visit the drawdowns tool.
Volatility
HRTX vs. SGMO - Volatility Comparison
The current volatility for Heron Therapeutics, Inc. (HRTX) is 38.95%, while Sangamo Therapeutics, Inc. (SGMO) has a volatility of 61.52%. This indicates that HRTX experiences smaller price fluctuations and is considered to be less risky than SGMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HRTX vs. SGMO - Financials Comparison
This section allows you to compare key financial metrics between Heron Therapeutics, Inc. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities